Low molecular weight heparin (parnaparin) for cardioembolic events prevention in patients with atrial fibrillation undergoing elective electrical cardioversion: a prospective cohort study.

Source:http://linkedlifedata.com/resource/pubmed/id/21082292

Download in:

View as

General Info

PMID
21082292